News
Detailed price information for Foghorn Therapeutics Inc (FHTX-Q) from The Globe and Mail including charting and trades.
compounds comprising an E3 ubiquitin ligase protein binding moiety covalently linked to probable global transcription activator SNF2L2 (SMARCA2; BAF190B; SNF2-α) and/or transcription activator BRG1 ...
By using this system, we show that BRG1, the enzymatic motor of the SWI–SNF chromatin‐remodelling complex, is recruited to the positioned nucleosome in a transcription elongation‐dependent manner and ...
Efficacy and safety of envafolimab plus platinum-based chemotherapy as neoadjuvant therapy in resectable stage IIb-IIIb NSCLC: A single-arm, prospective, exploratory study. This is an ASCO Meeting ...
This prompted a search for distant BRG1-dependent enhancers required for IFN-γ-induced activation of pIV. Figure 1: The CIITA locus and its four promoters, pI, pII, pIII and pIV.
A multimodal analysis of CT radiomics and clinical variables in predicting immunotherapy response for NSCLC.
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Proteins operate within dense interconnected ...
Aortic stenosis (AS) remains one of the most common forms of valve disease, with significant impact on patient survival. The disease is characterized by left ventricular outflow obstruction and ...
† Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K. ‡ Department of Chemistry, Physical and Theoretical Chemistry Laboratory, ...
† Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, James Black Centre, Dow Street, Dundee DD1 5EH, U.K. ‡ Department of Chemistry, University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results